Our latest news & events

Discover our latest updates below!

Latest News

  • News
  • Events
  • Press
  • Others
  • View all

The challenges facing cell therapy today

Profile

TreeFrog

May 5, 2026

All about cell therapy factsheet 1

Profile

TreeFrog

April 2, 2026

TREEFROG THERAPEUTICS ANNOUNCES CHANGES TO EXECUTIVE COMMITTEE WITH THE ARRIVAL OF MARK ROTHERA AS CHIEF EXECUTIVE OFFICER & BOARD MEMBER TO SPEARHEAD NEXT PHASE OF GROWTH

Profile

TreeFrog

December 16, 2025

TREEFROG THERAPEUTICS SECURES €30 MILLION FROM EUROPEAN INVESTMENT BANK (EIB) MARKING A SIGNIFICANT MILESTONE IN THE COMPANY’S JOURNEY TO ACCELERATE THE FIELD OF CELL THERAPY

Profile

TreeFrog

May 27, 2025

NEWS ANNONCEMENT

TREEFROG THERAPEUTICS PRESENTS DELIVERY STRATEGY FOR NEXT GENERATION 3D CELL THERAPY FORMAT FOR PARKINSON’S DISEASE AT THE 28TH ANNUAL ASGCT MEETING IN NEW ORLEANS  

Profile

TreeFrog

May 13, 2025

Overview of Parkinson’s Disease Clinical Trial Landscape

Profile

TreeFrog

April 10, 2025

TREEFROG THERAPEUTICS ENTERS INTO PIONEERING RESEARCH COLLABORATION IN IMMUNO-ONCOLOGY WITH THE UNIVERSITY OF PITTSBURGH

TREEFROG THERAPEUTICS ENTERS INTO PIONEERING RESEARCH COLLABORATION IN IMMUNO-ONCOLOGY WITH THE UNIVERSITY OF PITTSBURGH

Profile

TreeFrog

October 22, 2024

iPSC Clinical Trials Landscape illustration

Overview of iPSC Clinical Trials Landscape

Profile

TreeFrog

October 14, 2024

TREEFROG PUBLISHES RESULTS OF FIRST SUCCESSFUL BIOPRODUCTION OF A PARKINSON’S DISEASE CELL THERAPY IN SCALABLE BIOREACTOR IN NEUROTHERAPEUTICS JOURNAL

Profile

TreeFrog

October 1, 2024

TREEFROG THERAPEUTICS APPOINTS DR. PETER ANDERSEN AS CHIEF RESEARCH & DEVELOPMENT OFFICER

Profile

TreeFrog

July 29, 2024

NEWS ANNONCEMENT

TREEFROG THERAPEUTICS PARTICIPATES IN AN INNOVATION SHOWCASE & POSTER SESSION AT THE INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH (ISSCR) ANNUAL MEETING

Profile

TreeFrog

July 9, 2024

NEWS ANNONCEMENT

TreeFrog Therapeutics Picks-Up Best Poster Award At The International Society For Cell & Gene Therapy (ISCT) Annual Meeting For Their Cell Therapy Program In Parkinson’s Disease

TreeFrog Therapeutics Picks-Up Best Poster Award At The International Society For Cell & Gene Therapy (ISCT) Annual Meeting For Their Cell Therapy Program In Parkinson’s Disease

Profile

TreeFrog

May 29, 2024

NEWS ANNONCEMENT

TreeFrog Presents Data From Their Parkinson’s Disease Cell Therapy Program At The 29th World Congress On Parkinson’s Disease And Related Disorders (IAPRD) In Lisbon

TreeFrog Presents Data From Their Parkinson’s Disease Cell Therapy Program At The 29th World Congress On Parkinson’s Disease And Related Disorders (IAPRD) In Lisbon

Profile

TreeFrog

May 20, 2024

Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration to Optimize Production of Vertex’s Cell Therapies for Type 1 Diabetes

Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration to Optimize Production of Vertex’s Cell Therapies for Type 1 Diabetes

Profile

TreeFrog

April 23, 2024

NEWS ANNONCEMENT

TreeFrog Presents Data From Their Parkinson’s Cell Therapy Program At The American Academy Of Neurology Annual Meeting

TreeFrog Presents Data From Their Parkinson’s Cell Therapy Program At The American Academy Of Neurology Annual Meeting

Profile

TreeFrog

April 15, 2024

TreeFrog’s Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM)

TreeFrog’s Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM)

Profile

TreeFrog

March 21, 2024

TreeFrog Therapeutics reinforces Executive Committee with three new members

TreeFrog Therapeutics reinforces Executive Committee with three new members.

Profile

TreeFrog

November 9, 2023

Exponential hiPSC expansion in 10L bioreactors with C-Stem™ published in Biomaterials

Profile

TreeFrog

March 7, 2023

Gaia Biomedicine & TreeFrog Therapeutics announce collaboration for the expansion of allogeneic NK-like cells against solid tumors

GAIA BioMedicine, a Japan-based clinical-stage company pioneering allogeneic NK-like cell therapies against solid tumors, and TreeFrog Therapeutics, a global biotechnology company advancing a pipeline of cell therapies based on the biomimetic C-Stem™ technology platform, today announced they have entered into a collaboration for the expansion of donor-derived NK-like cells.

Profile

TreeFrog

February 15, 2023

Our blog “In the Stem Cell Jungle” is out

Profile

TreeFrog

February 14, 2023

TreeFrog Therapeutics moves to GMP manufacturing with cell encapsulation device delivered by Invetech

The machine will be transferred in 2023 to a contract development and manufacturing organization (CDMO) to produce TreeFrog’s cell therapy candidate for Parkinson’s disease, with the aim of a first-in-human trial in 2024. Over 2023, Invetech will deliver three additional GMP encapsulation devices to support TreeFrog’s in-house and partnered cell therapy programs in regenerative medicine and immuno-oncology.

Profile

TreeFrog

October 11, 2022

Peter Nell joins TreeFrog Therapeutics as Independent Board Member

Profile

TreeFrog

July 25, 2022

Umoja Biopharma and TreeFrog Therapeutics announce collaboration to address current challenges facing ex vivo allogeneic therapies in immuno-oncology

Profile

TreeFrog

June 10, 2022

TreeFrog Therapeutics expands Board with new independent members from the cell therapy industry

TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs.

Profile

TreeFrog

April 14, 2022

treefrog therapeutics kk japan kobe fbri

TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies

TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs.

Profile

TreeFrog

April 8, 2022

EIC ScalingUp TreeFrog Therapeutics

EIC ScalingUp TOP50: TreeFrog Therapeutics selected among 3,000 European Deeptech companies

Profile

TreeFrog

April 1, 2022

TreeFrog Therapeutics de retour dans le FrenchTech120

TreeFrog Therapeutics back in the FrenchTech120

The whole team at TreeFrog Therapeutics wishes you a Happy New Year !

Profile

TreeFrog

February 1, 2022

TreeFrog birthday 3 years cell therapy lab capacity france ips

TreeFrog celebrates its third birthday, announcing a two-fold increase in lab capacity !

TreeFrog Therapeutics celebrated its 3rd anniversary on December 7th, 2021, announcing that the company increase its clean room capacity by two-fold in Pessac, to support its acceleration in cell therapy.

Profile

TreeFrog

December 7, 2021

TreeFrog Therapeutics Awarded the Galien MedStartup Prize 2020 for its International Consortium on iPSC Quality with US, Japan & France

Profile

TreeFrog

October 28, 2021

Team - TreeFrog Therapeutics

TreeFrog Therapeutics secures $75M in Series B financing to advance a pipeline of stem cell-derived cell therapies and deploy proprietary C-Stem™ technology in the USA & Japan

TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75 million (€64M) Series B financing round, bringing the total funding to date to $83 million (€70M).

Profile

TreeFrog

September 13, 2021

Leap forward in cell therapy manufacturing: highly reproducible stem cell expansion in 10L bioreactors, with exponential growth and preserved quality

Leap forward in cell therapy manufacturing: data reveals highly reproducible stem cell expansion in 10L bioreactors, with exponential growth and preserved quality

Profile

TreeFrog

June 21, 2021

TreeFrog Therapeutics exponential iPS cell expansion in large scale bioreactor preserved cell quality

C-Stem™ outperforms 2D & aggregate cultures in benchmark of cell culture technologies for the mass-production of human induced pluripotent stem cells

Profile

TreeFrog

May 11, 2021

C-Stem technology mass-production of ips-derived cell therapy scale-up manufacturing in bioreactors

World first: TreeFrog Therapeutics announces the production of a single batch of 15 billion iPS cells in a 10L bioreactor with exponential amplification of 276-fold per week.

Profile

TreeFrog

April 12, 2021

TreeFrog Therapeutics(仏国ボルドー)、iPS細胞の品質に関する国際コンソーシアムでGalien MedStartup Prizeを受賞

TreeFrog Therapeutics(仏国ボルドー)、iPS細胞の品質に関する国際コンソーシアムでGalien MedStartup Prizeを受賞

Profile

TreeFrog

January 29, 2021

cellules-souches-pluripotentes-induites-autoorganisees-en-3D-dans-une-caspule-Treefrog-C-Stem-scaled-1

The French Blood Agency announces agreement with TreeFrog Therapeutics to scale-up manufacturing of iPS-derived hematopoietic stem cell transplants

Profile

TreeFrog

November 17, 2020

PRESENTING OUR CELL THERAPY PROGRAM FOR PARKINSON'S DISEASE AT NECTAR 2020

Presenting our cell therapy program for Parkinson’s disease at Nectar 2020 !

Profile

TreeFrog

November 11, 2020

TreeFrog-Therapeutics-Invetech-scale-up-cell-therapy-manufacturing-encapsulation-bioreactor

TreeFrog Therapeutics and Invetech expand partnership to transition high-throughput stem cell encapsulation technology to GMP system for commercial-scale cell therapy manufacturing

Profile

TreeFrog

October 7, 2020

TreeFrog nominated for the Prix Galien MedStartup Award !

TreeFrog nominated for the Prix Galien MedStartup Award !

Profile

TreeFrog

September 22, 2020

TreeFrog joins the Japanese Society for Regenerative Medicine

TreeFrog joins the Japanese Society for Regenerative Medicine

Profile

TreeFrog

June 18, 2020

360° video of our first industrial site !

360° video of our first industrial site !

Profile

TreeFrog

June 10, 2020

Press Release : TreeFrog Therapeutics opens its first facility dedicated to iPS cell therapy scale-up in Bordeaux, France

Press Release : TreeFrog Therapeutics opens its first facility dedicated to iPS cell therapy scale-up in Bordeaux, France

Profile

TreeFrog

June 9, 2020

C-Stem™ technology presented in London

C-Stem™ technology presented in London

Profile

TreeFrog

February 10, 2020

Press Release : TreeFrog Therapeutics brings in senior profiles to drive the advent of high-quality & affordable allogenic cell therapies

Press Release : TreeFrog Therapeutics brings in senior profiles to drive the advent of high-quality & affordable allogenic cell therapies

Profile

TreeFrog

February 5, 2020

TreeFrog Therapeutics now part of the French Tech 120 !

TreeFrog Therapeutics now part of the French Tech 120 !

Profile

TreeFrog

January 21, 2020

New video : How do we reduce cell therapy costs ?

New video : How do we reduce cell therapy costs ?

Profile

TreeFrog

January 8, 2020

TreeFrog named Deep Tech Pioneer

TreeFrog named Deep Tech Pioneer

Profile

TreeFrog

November 20, 2019

TreeFrog in Boston

TreeFrog in Boston !

Profile

TreeFrog

October 31, 2019

Press release : TreeFrog Therapeutics receives additional €3M non-dilutive funding

Press release : TreeFrog Therapeutics receives additional €3M non-dilutive funding

Profile

TreeFrog

September 5, 2019

TreeFrog Therapeutics raises over €7M ($7.8M)

TreeFrog Therapeutics raises over €7M ($7.8M)

Profile

TreeFrog

May 13, 2019

Press release : TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best in class quality check, to cell and gene therapy leader Imagine Institute

Press release : TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best in class quality check, to cell and gene therapy leader Imagine Institute

Profile

TreeFrog

April 15, 2019

New video : How do we encapsulate stem cells ?

Profile

TreeFrog

April 12, 2019

TreeFrog-Therapeutics-licence-AST-SATT-Aquitaine

Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert

Profile

TreeFrog

March 25, 2019

treefrog-therapeutics-i-lab-2018-bpifrance

TreeFrog wins the i-LAB innovation contest

Profile

TreeFrog

July 5, 2018

treefrog-therapeutics-i-lab-bpifrance

Vidéo : Treefrog founders at the i-LAB ceremony

treefrog therapeutics i-lab bpifrance

Profile

TreeFrog

Events

  • Pasts events
  • Upcoming events

No events found.

Ressources

Explore our resources to learn more

Please visit our resources section for insightful Stem Cell Blog entries, articles, publications, and much more.

Contact

Discover TreeFrog’s Cell Therapy Programs

Discover more